Mineralocorticoid receptor antagonists in dialysis patients after ACHIEVE and ALCHEMIST: updated systematic review and meta-analysis of 14 randomized trials. [PDF]
Ren FailZhu Y, Li J, Huang Z, Qiu F.
europepmc +1 more source
Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. [PDF]
MedComm (2020)Ravassa S +20 more
europepmc +1 more source
Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors Therapy. [PDF]
Clin Transl SciLin WR +7 more
europepmc +1 more source
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Diabetes Obes MetabZeitler E +4 more
europepmc +1 more source
Racial Differences in Dermatologic Treatment for Adolescents With PCOS-Related Acne Vulgaris. [PDF]
Pediatr DermatolGarcia S, Kenner-Bell B.
europepmc +1 more source
Prevalence and risk factors of potentially inappropriate medications at discharge in older adults with heart failure: A retrospective observational pharmacovigilance study. [PDF]
Medicine (Baltimore)Xu J, Zhang L, Ma H, Lu Y, Jiang Z.
europepmc +1 more source
A network pharmacology-guided multi-omics and spatial single-cell framework nominates WT1 as a spironolactone-linked immune biomarker in prostate cancer. [PDF]
Front PharmacolZhu Z, He X.
europepmc +1 more source
Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients. [PDF]
Int J Mol SciSecondulfo C +12 more
europepmc +1 more source
A Rare Case of Bartter Syndrome Type 3 Diagnosed in Elderly Age. [PDF]
Case Rep EndocrinolOkura T +5 more
europepmc +1 more source